What NADH dose do studies and labels give?

Strengths and directions on labels
ProductNADH per unitDirections
Nutra-Z+ (multi-ingredient label)5 mg per serving; the label lists a serving size of 1 tablet for a capsule product51 capsule once daily, preferably with meals or as directed by medical practitioner5
NADH CONSTANT (maker's European product)20 mg per tablet62 tablets in the morning and 2 at lunchtime, on a pharmacy page that also lists a daily dose of 1 tablet (20 mg)6; a maker's page states a daily NADH dose of 80 mg4
NADH Plus (homeopathic spray)Nadidum 4X71 spray orally 3 times a day or as directed by a health care professional7

Trials in chronic fatigue syndrome gave 10 mg or 20 mg of NADH by mouth, alone or with coenzyme Q10, a maker's European page gives 80 mg a day, and searches of DailyMed, PubMed, the trial registry and RxList found no label or regulator that gives a usual NADH dose.1234

Strengths and directions on labels

The table is set at the top of the page

Searches of DailyMed, PubMed, the trial registry and RxList found no label or regulator that gives a usual NADH dose. Virexa, another multi-ingredient label that lists NADH without an amount, gives a usual adult dose of 1 tablet once or twice daily or as prescribed by a licensed medical practitioner.8

RxList, a consumer reference rather than a label, gives 10 mg as the amount each day, in a passage saying NADH seems safe for most people in the short term, up to 12 weeks.9 It also says the appropriate dose depends on several factors such as the user's age and health, and that there is not enough scientific information to determine an appropriate range of doses.9

Doses used in trials

Trials in chronic fatigue syndrome (CFS) used 10 to 20 mg of NADH, alone or with coenzyme Q10 (CoQ10).123

TrialDose and schedulePeopleLength
Forsyth 1999110 mg NADH alone or placebo, then crossed over26 patients4 weeks per period, 4-week washout
Alegre 2010220 mg oral NADH alone or placebo86 enrolled, 77 completed3 months, treatment in the first two months
Castro-Marrero 2015320 mg/day NADH plus 200 mg/day CoQ10 in soft gel capsules, or matching placebo73 women (thirty-nine active, thirty-four placebo)8 weeks
Castro-Marrero ME/CFS trial10200 mg CoQ10 and 20 mg NADH or matching placebo, once daily (as the paper's summary gives it)207 patients (104 and 103)12-week trial: 8 weeks of treatment, then a visit four weeks after treatment ended

The same paper's methods give 72 patients in each arm, given four capsules daily for eight weeks while all also received their standard therapy, so its figures differ from the summary's.10

In the jet lag trial (Birkmayer 2002), thirty-five healthy, employed people were randomised on arrival to 20 mg of sublingual stabilised NADH (n = 18) or identical placebo tablets (n = 17).11

Registry entry NCT03186027 (282 enrolled), the entry for the later Castro-Marrero ME/CFS trial, lists NADH 20 mg/day with CoQ10 200 mg/day as 4 tablets/day for 8 weeks, divided into 2 daily doses (2 tablets before breakfast and 2 before lunch), each tablet holding CoQ10 50 mg plus NADH 5 mg, against placebo on the same schedule.1210 Registry entry NCT02063126 (80 enrolled), under which the 2015 Castro-Marrero trial of 73 women was registered, lists NADH 20 mg/day plus CoQ10 200 mg/day divided into two daily doses (2 tablets before breakfast, 2 before lunch), against placebo on the same schedule.133

How NADH is taken

No label states a route for NADH alone. The 2015 CFS trial gave it by mouth in soft gel capsules, the later CFS trial paper describes four enteric-coated tablets daily in one passage and four capsules daily in another, and the jet lag trial gave sublingual stabilised NADH against identical placebo tablets.31011

Storage

The Nutra-Z+ and Virexa labels, both multi-ingredient products, give storage at 20 to 25 C with excursions permitted to 15 to 30 C, and the Virexa label adds a cool dry place.58 The DailyMed search found storage only for multi-ingredient products, and no NADH-specific stability data.

Frequently asked questions

What is the maximum NADH dose?

Searches of PubMed, DailyMed and RxList found no maximum NADH dose from a label or regulator. A 2024 systematic review of 10 randomised trials (489 participants) of NAD+ and NADH says NADH supplementation is safe and has a low incidence of side effects, notes that all studies showed some side effects, and calls for future work on the doses given.14 The later ME/CFS trial of NADH with CoQ10 (Castro-Marrero, 207 patients) reported no serious adverse events and no relevant treatment-related adverse events, while 19 participants dropped out due to adverse effects: eight in the active group (five epigastralgias and three dizziness) and 11 in the placebo group.10

Is NADH mixed from powder and drawn into a syringe?

A search of DailyMed and maker pages found no label or leaflet for mixing NADH powder, so there is no water volume or syringe mark to work out.

References

  1. PubMed. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. 1999. pubmed.ncbi.nlm.nih.gov
  2. PubMed. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome]. 2010. pubmed.ncbi.nlm.nih.gov
  3. PMC. Does Oral Coenzyme Q10 Plus NADH Supplementation Improve Fatigue and Biochemical Parameters in Chronic Fatigue Syndrome?. 2015. pmc.ncbi.nlm.nih.gov
  4. Birkmayer (via Ingredients Network). Prof. George Birkmayer NADH CONSTANT | Prof. George Birkmayer NADH | Ingredients Network. ingredientsnetwork.com
  5. DailyMed. Nutra-Z+ Capsules. 2022. dailymed.nlm.nih.gov
  6. Birkmayer (via onlineapo.at). Prof George Birkmayer NADH CONSTANT Tablets. onlineapo.at
  7. DailyMed. DRUG FACTS:. 2026. dailymed.nlm.nih.gov
  8. DailyMed. Virexa. 2025. dailymed.nlm.nih.gov
  9. RxList. Nadh: Health Benefits, Side Effects, Uses, Dose & Precautions. rxlist.com
  10. PMC. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. 2021. pmc.ncbi.nlm.nih.gov
  11. PubMed. [Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit]. 2002. pubmed.ncbi.nlm.nih.gov
  12. ClinicalTrials.gov. NCT03186027: Coenzyme Q10 Plus NADH Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. 2021. clinicaltrials.gov
  13. ClinicalTrials.gov. NCT02063126: Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS. 2013. clinicaltrials.gov
  14. PubMed. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. 2024. pubmed.ncbi.nlm.nih.gov